info@seagull-health.com
SeagullHealth
search
Rasburicase(Fasturtec)
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.
Fasturtec(Rasburicase) Instructions:Uses,Dosage, Side Effects
Elitek is a recombinant urate-oxidase enzyme, produced via genetically modified Saccharomyces cerevisiae, for intravenous use. It is formulated as a lyophilized powder requiring reconstitution.
Its primary mechanism of action is the catalytic oxidation of uric acid into the more soluble metabolite allantoin, facilitating its excretion. It is specifically indicated for the management of hyperuricemia in the context of anticipated tumor lysis syndrome (TLS) in patients receiving cytotoxic therapy.
Elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, or solid tumor malignancies who are receiving anticancer therapy expected to cause tumor lysis and subsequent elevation of plasma uric acid. It is approved only for a single treatment course.
Recommended dose: 0.2 mg/kg administered as a 30-minute intravenous infusion once daily for up to 5 days.
- Core products
- Antitumor drugs
- General drug
- Antiviral drugs
- Biological agents
- haiousales@gmail.com
